Catalyst Wire Dossier Catalyst Wire Dossier

GCC4401C

· Green Cross Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GCC4401C, covering 2012-08-29 to 2012-08-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers [Phase 1]

See pricing